Assignee
OP T LLC
US·6 granted patents·7 pending applications·9 citations·filing 2018–2024
Top patents by PatentIndex Score
13 records- 0192US12048734B2Bioactive peptides and methods of use thereofOP T LLC·Filed 2021·Granted Jul 30, 2024·3 cites·14 claims
- 0292US11744875B2Peptides and methods for treating diseaseOP T LLC·Filed 2020·Granted Sep 5, 2023·3 cites·21 claims
- 0390US11793854B2Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD150 interactionOP T LLC·Filed 2020·Granted Oct 24, 2023·3 cites·8 claims
- 0478US2024374686A1Peptides and methods for treating diseasesOP T LLC·Filed 2024·Application pending·0 cites
- 0577US12472223B2Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD154 interactionOP T LLC·Filed 2023·Granted Nov 18, 2025·0 cites·8 claims
- 0677US12226450B2Peptides and methods for treating diseaseOP T LLC·Filed 2022·Granted Feb 18, 2025·0 cites·20 claims
- 0772US2025018012A1Bioactive peptides and methods of use thereofOP T LLC·Filed 2024·Application pending·0 cites
- 0868US12428465B2Therapeutic peptides and methods for treating type 2 diabetesOP T LLC·Filed 2021·Granted Sep 30, 2025·0 cites·20 claims
- 0959US2019263888A1Therapeutic peptides and methods for treating autoimmune related diseaseOP T LLC·Filed 2019·Application pending·0 cites
- 1052US2022031632A1Nanoparticle compositions and uses thereofOP T LLC·Filed 2021·Application pending·0 cites
- 1148US2019194290A1Methods for preventing, modulating and/or reducing cardiovascular diseaseOP T LLC·Filed 2018·Application pending·0 cites
- 1247US2020072837A1Methods for preventing, modulating and/or reducing cardiovascular diseaseOP T LLC·Filed 2019·Application pending·0 cites
- 1347US2020326333A1Diagnosis and treatment of autoimmune diseasesOP T LLC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →